Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 30,432 | 26,566 |
| Marketable Securities | 73,143 | 70,179 |
| Receivables | 11,996 | 4,448 |
| Inventories | 13,320 | 1,245 |
| TOTAL | $132,923 | $103,621 |
| Non-Current Assets | ||
| PPE Net | 4,776 | 2,476 |
| Other Non-Current Assets | 11,946 | 3,943 |
| TOTAL | $16,722 | $6,419 |
| Total Assets | $149,645 | $110,040 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,852 | 1,166 |
| Accrued Expenses | 15,828 | 8,128 |
| TOTAL | $21,148 | $10,605 |
| Non-Current Liabilities | ||
| Deferred Revenues | 939 | 87 |
| Other Non-Current Liabilities | 371,997 | 302,285 |
| TOTAL | $373,857 | $302,540 |
| Total Liabilities | $395,005 | $313,145 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -296,737 | -229,664 |
| Other shareholders' equity | 65 | 137 |
| TOTAL | $-245,360 | $-203,105 |
| Total Liabilities And Equity | $149,645 | $110,040 |